Advancing Breast Health: The role of 3D Tomosynthesis in the fight against Breast CancerWomen and Fetal Imaging Center (WAFI), Cairo, Egypt
Courtesy of Dr. Hanan Gewefel, Consultant of Diagnostic Breast Imaging and Dr. Sara Khodair, Breast Imaging Specialist



Introduction

Breast cancer remains the most common cancer among women worldwide, posing significant challenges to healthcare systems globally. Early detection is critical, and advancements in imaging technologies, such as 3D Tomosynthesis mammography, are revolutionizing breast cancer screening and diagnosis. With the use of 50° Wide-Angle Tomosynthesis technology (Siemens Healthineers, Erlangen, Germany), clinicians can overcome the limitations posed by overlapping tissue, achieving exceptional depth resolution and superior mass detectability. Innovative features like PRIME Technology’s intelligent software algorithm significantly reduce radiation dose without compromising image quality. The Gridless acquisition technique eliminates the need for radiation-absorbing grids, improving imaging efficiency.

Additionally, OpDose technology optimizes exposure parameters based on breast density and thickness, while 1-view tomosynthesis offers comprehensive 3D imaging at a reduced radiation dose compared to standard 2-view mammography. Insight 2D minimizes the need for additional full-field digital mammography (FFDM) images, representing an economical, patient-centered approach to breast health.

These advancements empower clinicians with enhanced diagnostic accuracy, ensuring the highest levels of specificity and sensitivity in breast imaging. From initial detection to recovery, this technology fosters confident clinical decisions, transforming the fight against breast cancer.

Dr. Hanan Gewefel
Dr. Sara Khodair